禾元生物:2025年度业绩快报公告

Group 1 - The core point of the article is that He Yuan Bio reported a significant increase in total operating revenue for the year 2025, amounting to 47.8614 million yuan, which represents a year-on-year growth of 89.80% [2] - The net profit attributable to the parent company's shareholders for 2025 was reported as -157.9449 million yuan, indicating a loss [2]

Wuhan Healthgen Biotechnology Corp.-禾元生物:2025年度业绩快报公告 - Reportify